AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
CHARACTERISTICS OF OVARIES PROPHYLACTICALLY REMOVED FROM WOMEN WITH AFAMILY HISTORY OF OVARIAN-CANCER
Authors: AFIFY AM BIELAT KL ELTABBAKH GH PIVER MS PATTERSON JM WERNESS BA
Citation: Am. Afify et al., CHARACTERISTICS OF OVARIES PROPHYLACTICALLY REMOVED FROM WOMEN WITH AFAMILY HISTORY OF OVARIAN-CANCER, Modern pathology, 11(1), 1998, pp. 100-100
EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA
Authors: ELTABBAKH GH PIVER MS
Citation: Gh. Eltabbakh et Ms. Piver, EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA, Oncology, 12(6), 1998, pp. 813-819
THE CLINICAL-VALUE OF DIGENE HYBRID CAPTURE HPV DNA TESTING IN A REFERRAL-BASED POPULATION WITH ABNORMAL PAP SMEARS
Authors: RECIO FO SRIVASTAVA BIS WONG C HEMPLING RE ELTABBAKH GH PIVER MS
Citation: Fo. Recio et al., THE CLINICAL-VALUE OF DIGENE HYBRID CAPTURE HPV DNA TESTING IN A REFERRAL-BASED POPULATION WITH ABNORMAL PAP SMEARS, European journal of gynaecological oncology, 19(3), 1998, pp. 203-208
PROSPECTIVE SEQUENTIAL TRIALS OF INDUCTION WEEKLY CISPLATIN FOLLOWED BY MONTHLY CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL ANDCISPLATIN IN OPTIMAL (LESS-THAN-OR-EQUAL-TO-1 CM) STAGE-III AND STAGE-IV OVARIAN-CANCER
Authors: PIVER MS ELTABBAKH GH HEMPLING RE RECIO FO BLUMENSON LE
Citation: Ms. Piver et al., PROSPECTIVE SEQUENTIAL TRIALS OF INDUCTION WEEKLY CISPLATIN FOLLOWED BY MONTHLY CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL ANDCISPLATIN IN OPTIMAL (LESS-THAN-OR-EQUAL-TO-1 CM) STAGE-III AND STAGE-IV OVARIAN-CANCER, European journal of gynaecological oncology, 19(1), 1998, pp. 5-10
LAPAROSCOPIC-ASSISTED APPLICATION OF INTERSTITIAL BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PILOT-STUDY
Authors: RECIO FO PIVER MS HEMPLING RE ELTABBAKH GH HAHN S
Citation: Fo. Recio et al., LAPAROSCOPIC-ASSISTED APPLICATION OF INTERSTITIAL BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PILOT-STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 411-414
STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS
Authors: SILVER DF HEMPLING RE PIVER MS RECIO FO ELTABBAKH GH
Citation: Df. Silver et al., STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS, American journal of clinical oncology, 21(5), 1998, pp. 431-435
PROGESTERONE-RECEPTOR STATUS IS A SIGNIFICANT PROGNOSTIC VARIABLE OF PROGRESSION-FREE SURVIVAL IN ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: HEMPLING RE PIVER MS ELTABBAKH GH RECIO FO
Citation: Re. Hempling et al., PROGESTERONE-RECEPTOR STATUS IS A SIGNIFICANT PROGNOSTIC VARIABLE OF PROGRESSION-FREE SURVIVAL IN ADVANCED EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 447-451
COMPLICATIONS RELATED TO INDWELLING CAVAL CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE
Authors: SILVER DF HEMPLING RE RECIO FO PIVER MS ELTABBAKH GH
Citation: Df. Silver et al., COMPLICATIONS RELATED TO INDWELLING CAVAL CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE, Gynecologic oncology (Print), 70(3), 1998, pp. 329-333
CORRELATION BETWEEN EXTREME DRUG-RESISTANCE ASSAY AND RESPONSE TO PRIMARY PACLITAXEL AND CISPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER
Authors: ELTABBAKH GH PIVER MS HEMPLING RE RECIO FO LELE SB MARCHETTI DL BAKER TR BLUMENSON LE
Citation: Gh. Eltabbakh et al., CORRELATION BETWEEN EXTREME DRUG-RESISTANCE ASSAY AND RESPONSE TO PRIMARY PACLITAXEL AND CISPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 392-397
REMARKABLE RESPONSE OF PRIMARY SQUAMOUS-CELL CARCINOMA OF THE OVARY TO PACLITAXEL AND CISPLATIN
Authors: ELTABBAKH GH HEMPLING RE RECIO FO ONEILL CP
Citation: Gh. Eltabbakh et al., REMARKABLE RESPONSE OF PRIMARY SQUAMOUS-CELL CARCINOMA OF THE OVARY TO PACLITAXEL AND CISPLATIN, Obstetrics and gynecology, 91(5), 1998, pp. 844-846
EPIDEMIOLOGIC DIFFERENCES BETWEEN WOMEN WITH EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA AND WOMEN WITH EPITHELIAL OVARIAN-CANCER
Authors: ELTABBAKH GH PIVER MS NATARAJAN N METTLIN CJ
Citation: Gh. Eltabbakh et al., EPIDEMIOLOGIC DIFFERENCES BETWEEN WOMEN WITH EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA AND WOMEN WITH EPITHELIAL OVARIAN-CANCER, Obstetrics and gynecology, 91(2), 1998, pp. 254-259
ELEVATED SERUM CA-125 CONCENTRATION IN A PATIENT WITH TUBERCULOUS PERITONITIS MIMICKING OVARIAN-CANCER - REPLY
Authors: ELTABBAKH GH
Citation: Gh. Eltabbakh, ELEVATED SERUM CA-125 CONCENTRATION IN A PATIENT WITH TUBERCULOUS PERITONITIS MIMICKING OVARIAN-CANCER - REPLY, Journal of reproductive medicine, 43(7), 1998, pp. 636-636
IMPORTANCE OF LYMPH-NODE METASTASES IN PRIMARY PERITONEAL CARCINOMA
Authors: ELTABBAKH GH PIVER MS HEMPLING RE WERNESS BA BLUMENSON LE
Citation: Gh. Eltabbakh et al., IMPORTANCE OF LYMPH-NODE METASTASES IN PRIMARY PERITONEAL CARCINOMA, Journal of surgical oncology, 68(3), 1998, pp. 144-148
EXCELLENT LONG-TERM SURVIVAL AND ABSENCE OF VAGINAL RECURRENCES IN 332 PATIENTS WITH LOW-RISK STAGE-I ENDOMETRIAL ADENOCARCINOMA TREATED WITH HYSTERECTOMY AND VAGINAL BRACHYTHERAPY WITHOUT FORMAL STAGING LYMPH-NODE SAMPLING - REPORT OF A PROSPECTIVE TRIAL
Authors: ELTABBAKH GH PIVER MS HEMPLING RE SHIN KH
Citation: Gh. Eltabbakh et al., EXCELLENT LONG-TERM SURVIVAL AND ABSENCE OF VAGINAL RECURRENCES IN 332 PATIENTS WITH LOW-RISK STAGE-I ENDOMETRIAL ADENOCARCINOMA TREATED WITH HYSTERECTOMY AND VAGINAL BRACHYTHERAPY WITHOUT FORMAL STAGING LYMPH-NODE SAMPLING - REPORT OF A PROSPECTIVE TRIAL, International journal of radiation oncology, biology, physics, 38(2), 1997, pp. 373-380
THE ADDITION OF BLEOMYCIN AND DOSE-ESCALATED IFOSFAMIDE TO THE COMBINATION OF CISPLATIN PLUS IFOSFAMIDE DOES NOT IMPROVE SURVIVAL IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA
Authors: HEMPLING RE ELTABBAKH GH PIVER MS RECIO FO ONEILL CP
Citation: Re. Hempling et al., THE ADDITION OF BLEOMYCIN AND DOSE-ESCALATED IFOSFAMIDE TO THE COMBINATION OF CISPLATIN PLUS IFOSFAMIDE DOES NOT IMPROVE SURVIVAL IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA, American journal of clinical oncology, 20(3), 1997, pp. 315-318
OSTEOSARCOMA METASTATIC TO THE OVARY - A CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: ELTABBAKH GH BELINSON JL BISCOTTI CV
Citation: Gh. Eltabbakh et al., OSTEOSARCOMA METASTATIC TO THE OVARY - A CASE-REPORT AND REVIEW OF THE LITERATURE, International journal of gynecological pathology, 16(1), 1997, pp. 76-78
2 SEQUENTIAL STUDIES FOR PRIMARY PERITONEAL CARCINOMA - INDUCTION WITH WEEKLY CISPLATIN FOLLOWED BY EITHER CISPLATIN-DOXORUBICIN-CYCLOPHOSPHAMIDE OR PACLITAXEL-CISPLATIN
Authors: PIVER MS ELTABBAKH GH HEMPLING RE RECIO FO BLUMENSON LE
Citation: Ms. Piver et al., 2 SEQUENTIAL STUDIES FOR PRIMARY PERITONEAL CARCINOMA - INDUCTION WITH WEEKLY CISPLATIN FOLLOWED BY EITHER CISPLATIN-DOXORUBICIN-CYCLOPHOSPHAMIDE OR PACLITAXEL-CISPLATIN, Gynecologic oncology, 67(2), 1997, pp. 141-146
THE INFERIOR GLUTEAL FLAP IN THE DIFFICULT VULVAR AND PERINEAL RECONSTRUCTION
Authors: LOREE TR HEMPLING RE ELTABBAKH GH RECIO FO PIVER MS
Citation: Tr. Loree et al., THE INFERIOR GLUTEAL FLAP IN THE DIFFICULT VULVAR AND PERINEAL RECONSTRUCTION, Gynecologic oncology, 66(3), 1997, pp. 429-434
ESTROGEN REPLACEMENT THERAPY FOLLOWING OOPHORECTOMY IN WOMEN WITH A FAMILY HISTORY OF OVARIAN-CANCER
Authors: ELTABBAKH GH PIVER MS HEMPLING RE RECIO FO AIDUK C
Citation: Gh. Eltabbakh et al., ESTROGEN REPLACEMENT THERAPY FOLLOWING OOPHORECTOMY IN WOMEN WITH A FAMILY HISTORY OF OVARIAN-CANCER, Gynecologic oncology, 66(1), 1997, pp. 103-107
PRIMARY PERITONEAL ADENOCARCINOMA METASTATIC TO THE BRAIN
Authors: ELTABBAKH GH PIVER MS WERNESS BA
Citation: Gh. Eltabbakh et al., PRIMARY PERITONEAL ADENOCARCINOMA METASTATIC TO THE BRAIN, Gynecologic oncology, 66(1), 1997, pp. 160-163
P53 AND HER-2 NEU OVEREXPRESSION IN OVARIAN BORDERLINE TUMORS/
Authors: ELTABBAKH GH BELINSON JL KENNEDY AW BISCOTTI CV CASEY G TUBBS RR
Citation: Gh. Eltabbakh et al., P53 AND HER-2 NEU OVEREXPRESSION IN OVARIAN BORDERLINE TUMORS/, Gynecologic oncology, 65(2), 1997, pp. 218-224
TELOMERASE IN GYNECOLOGIC CANCERS
Authors: ELTABBAKH GH
Citation: Gh. Eltabbakh, TELOMERASE IN GYNECOLOGIC CANCERS, Obstetrics and gynecology, 90(6), 1997, pp. 1015-1019
SERUM CA-125 MEASUREMENTS GREATER-THAN-65 U ML - CLINICAL-VALUE/
Authors: ELTABBAKH GH BELINSON JL KENNEDY AW GUPTA M WEBSTER K BLUMENSON LE
Citation: Gh. Eltabbakh et al., SERUM CA-125 MEASUREMENTS GREATER-THAN-65 U ML - CLINICAL-VALUE/, Journal of reproductive medicine, 42(10), 1997, pp. 617-624
P53 OVEREXPRESSION IS NOT AN INDEPENDENT PROGNOSTIC FACTOR FOR PATIENTS WITH PRIMARY OVARIAN EPITHELIAL CANCER
Authors: ELTABBAKH GH BELINSON JL KENNEDY AW BISCOTTI CV CASEY G TUBBS RR BLUMENSON LE
Citation: Gh. Eltabbakh et al., P53 OVEREXPRESSION IS NOT AN INDEPENDENT PROGNOSTIC FACTOR FOR PATIENTS WITH PRIMARY OVARIAN EPITHELIAL CANCER, Cancer, 80(5), 1997, pp. 892-898
INVASIVE ADENOCARCINOMA OF THE CERVIX FOLLOWING LLETZ (LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE) FOR ADENOCARCINOMA IN-SITU
Authors: KENNEDY AW ELTABBAKH GH BISCOTTI CV WIRTH S
Citation: Aw. Kennedy et al., INVASIVE ADENOCARCINOMA OF THE CERVIX FOLLOWING LLETZ (LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE) FOR ADENOCARCINOMA IN-SITU, Gynecologic oncology, 58(2), 1995, pp. 274-277
Risultati: 1-25 | 26-31